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ABSTRACT

ARTICLE HISTORY

The objective of this study was to identify factors at the individual, provider, and systems levels that serve
as challenges or opportunities for increasing adolescent vaccination—including Human Papillomavirus
(HPV) vaccination—in rural communities in the southern United States (US). As part of a broader study to
increase HPV vaccine uptake in the southern US, we conducted in-depth interviews with vaccination
stakeholders representing public health and education agencies in North Carolina (NC) and South Carolina
(SC). Fourteen key stakeholders were recruited using purposive sampling to obtain insights into chal
lenges and solutions to rural-urban disparities in HPV vaccination coverage. Stakeholders were also
queried about their experiences and attitudes toward school-based vaccination promotion programs
and campaigns. We used a rapid qualitative approach to analyze the data. Stakeholders identified factors
at the individual, provider, and systems levels that serve as challenges to vaccination in rural communities.
Similar to previous studies, stakeholders mentioned challenges with healthcare access and vaccinerelated misconceptions that pose barriers to HPV vaccination for rural residents. Systems-level challenges
identified included limited access to high-speed internet in rural areas that may impact providers’ ability
to interface with state-level digital systems such as the vaccination registry. Stakeholders identified
a number of opportunities to increase HPV vaccination coverage, including through school-based health
promotion programs. Stakeholders strongly supported school-based programs and approaches to
strengthen confidence and demand for HPV vaccination and to help address persistent social determi
nants and system level factors that pose challenges to HPV vaccination coverage in many rural areas.
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Introduction
Each year, HPV infections cause approximately 36,000 cancers
in the US, including the majority of anal, cervical, vulvar,
penile, and oropharyngeal cancer cases among men and
women.1 The majority (92%) of these HPV attributable cancers
could have been prevented by the HPV vaccine, which is
recommended for routine vaccination at ages 11–12 years.1
Though the vaccine provides significant protection against
the oncogenic strains of HPV, rates of vaccine coverage
among adolescents, defined as uptake (getting the first dose)
and completion (getting all recommended doses), continue to
lag behind those of other recommended adolescent vaccines
and are below the Healthy People 2030 target of 80% coverage
among adolescents nationally.2,3
There are rural-urban disparities in the uptake and comple
tion of the HPV vaccination series.4 Several factors that influ
ence rural-urban disparities in HPV vaccination coverage have
been identified in the literature, including parental knowledge
and attitudes about HPV, knowledge about the vaccine, and
provider recommendations for vaccination.4–12 By contrast,
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uptake for other adolescent vaccines, particularly Tdap and
MenACWY was similar among rural and urban youth, indicat
ing challenges that are specific to the uptake of the HPV
vaccine in rural areas. Closer examination of urban-rural dif
ferences indicate that the geographic disparities may be present
only for adolescents at or above the poverty level, suggesting
that higher socioeconomic status may be a moderating factor
in the association between rurality and HPV vaccination.4,13
Historically, adolescents in the southern US have had the low
est rates of HPV vaccination.6 In 2019, rates of HPV vaccine
uptake in North Carolina (NC) (71.3%) and South Carolina
(SC) (71.8%) were similar to the national average (71.5%),4
however, completion rates in NC and SC are below the national
average.2,14 Further exploration of the drivers of rural-urban
disparities and important subgroup differences is an important
first step toward developing effective interventions and cam
paigns to promote HPV vaccination.
As part of a broader study to develop and evaluate a schoolbased intervention to reduce rural-urban disparities in HPV vac
cination in the southern US, we conducted semi-structured in-
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depth interviews with vaccination stakeholders and provi
ders from NC and SC to learn more about barriers and
opportunities to scaling up adolescent vaccination—
including HPV vaccination—in rural areas. We applied
a social-ecological framework to explore challenges to
vaccination, potential solutions to HPV vaccination dispa
rities, and suggestions for the design of school-based pro
grams aimed at increasing HPV vaccination rates in rural
areas. The social-ecological approach prioritizes under
standing health challenges and health promotion within
the context of individual and interpersonal factors; insti
tutional and community factors; and social, economic, and
political factors.15 Our aim was specifically to identify
factors at the individual, provider, and systems levels
that serve as challenges to adolescent vaccination in rural
communities in NC and SC and to generate potential
solutions that are acceptable and feasible to key vaccina
tion stakeholders.

Methods
Setting and design
This qualitative descriptive study involved completing indi
vidual interviews with a purposive sample of key stake
holders in NC and SC to obtain insights into the multifaceted drivers of rural-urban disparities in HPV vaccine
coverage. The details of the methods and analysis of this
study are presented according to the Consolidated Criteria
for Reporting Qualitative Research (COREQ) checklist.16
The study protocol was approved by the Duke University
Health System’s (DUHS) Institutional Review Board
(Pro00101137), and the University of South Carolina’s
Institutional Review Board (Authorization agreement for
reliance on DUHS IRB; Pro00085811). Since the Centers
for Disease Control and Prevention (CDC) only had access

Figure 1. Stakeholder interview guide.

to de-identified data, it was determined that the CDC was
not engaged in human subjects research and CDC’s IRB
approval was not required.
Sampling and recruitment
From November 2019 – January 2020, the first and second
authors conducted semi-structured individual interviews with
14 key stakeholders in NC and SC. The first author is
a behavioral scientist and the second author is a pediatric school
psychologist. Both have doctoral degrees and extensive experi
ence conducting qualitative research with patients, community
members, providers, and key stakeholders. Key stakeholders
identified for participation in this study were involved in HPV
vaccination efforts in North Carolina (n = 8) and South Carolina
(n = 6). They included statewide and regional public health and
public school officials working in the area of adolescent vaccina
tion, leaders from relevant statewide professional organizations
(e.g., pediatrics, school nursing), rural health officials, and pro
viders engaged in the delivery of vaccination services to rural
youth. Key stakeholders were recruited through e-mails and
phone calls introducing the study purpose and procedures.
Data collection
The study team developed a semi-structured interview guide to
gather stakeholders’ insights into the landscape of HPV vaccina
tion in rural NC and SC, including challenges to HPV vaccina
tion in rural settings, and the relevance and feasibility of school
settings for implementing HPV vaccination promotion cam
paigns and interventions (Figure 1). All participants reviewed
the purpose of the study and signed an electronic or written
consent form prior to participation. Interviews were conducted
in English by the first and second author, in-person or via
telephone. All interviews were audio-recorded and profession
ally transcribed to facilitate data analysis. Given that qualitative
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research aims to investigate factors that underlie behavior and is
concerned more with the richness than the representativeness of
data, meaningful data emerge from smaller, focused samples.
For qualitative interviews and focus groups, evidence suggests
that data saturation can occur within 12 interviews, with primary
themes arising as early as six interviews.17
Data analysis
We used a rapid qualitative analysis approach to analyze the
stakeholder interview data.18–20 We developed a deductive coding
template based on the interview guide to structure the analysis.
The coding template included three primary areas for data sum
marization based on the aims of the research: 1) challenges to
HPV vaccination uptake in rural areas of NC and SC, and 2)
opportunities to improve rural HPV vaccine coverage and thus
reduce rural-urban HPV vaccination disparities, and 3) feedback
on school-based interventions. After developing the template, our
team tested the coding template by having three separate mem
bers of the research team code two transcripts, compare, and
resolve discrepancies. After initial coding, the template was
revised and the remaining 12 transcripts were double coded by
two members of the research team, including the first and second
author who conducted the interviews. The team met to discuss
and reconcile discrepancies between coders to yield a single coded
template for each key stakeholder. Data from the coded templates
for each stakeholder were then put in a matrix to analyze the
depth and breadth of information in each domain.21 We used the
Social Ecological Model15as an organizing framework for identi
fying challenges and opportunities to rural HPV vaccination.

Results
We interviewed stakeholders from state public health and
education agencies in NC (n = 8) and SC (n = 6). Stakeholders
from the NC and SC public health departments included senior
administrative supervisors and medical consultants for immu
nization and children’s health as well as program managers
responsible for overseeing adolescent health programs, vacci
nation programs, and rural health programs (n = 9).
Stakeholders from NC and SC education agencies included
a senior administrative supervisor with knowledge of vaccina
tion programs in the public schools, and staff (PA/RN) respon
sible for implementing and monitoring vaccination programs
in schools (n = 3). We also interviewed stakeholders working
with community based organizations involved in vaccine pro
grams (n = 2). Several challenges and opportunities to improve
HPV vaccine coverage among rural adolescents were identified
at the individual, provider, and systems levels of the socialecological framework. Exemplar quotes for challenges are
shown in Table 1 and opportunities are shown in Table 2.
Individual level
Stakeholders identified multiple challenges to scaling up HPV
vaccine uptake in rural areas, including lack of knowledge;
negative attitudes and norms related to HPV infection; con
sequences of infection and HPV vaccination; and fears and
concerns about the vaccine. Stakeholders reported that there
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were limited opportunities for parents to receive education
about HPV infection and vaccination in rural communities
and identified lack of access to comprehensive, high quality
sexual health education as a persistent challenge.
In addition, a number of stakeholders reported that mis
information about the safety of the vaccine continues to limit
HPV vaccine uptake. Stakeholders indicated that many parents
have concerns about the side effects of HPV vaccination and/or
report having heard stories about adolescents who were alleg
edly harmed or killed by the HPV vaccine. Some stakeholders
reported continued concerns among rural parents that HPV
vaccination promoted sexual activity among youth, with one
stakeholder stating “it’s [seen as] the ‘permission to have sex’
vaccine.” Other stakeholders observed that this concern,
although present, is not as prevalent now as it was in the past.
Attitudes toward engagement in care—specifically preven
tive care—were also mentioned by a number of stakeholders.
Stakeholders reported that engaging in preventive care is some
times seen as a sort of ‘luxury’ for individuals in rural commu
nities, particularly those who are made vulnerable by various
social determinants of health (e.g., poverty, transportation
challenges, housing challenges).
Stakeholders emphasized the trusted and important role of
schools in rural communities as a potential way to overcome
parent misinformation or mistrust. Stakeholders discussed that
school-based programs should stress the importance of HPV
vaccination for girls and boys to prevent cancer. Stakeholders
suggested using diverse strategies to deliver vaccination infor
mation to rural parents due to challenges associated with
broadband access. They also suggested use of broader informa
tion sharing strategies included sending brochures/handouts
home with students, using social media or online resources to
distribute information from public health sources, including
the local health department, and leveraging health fairs and
other community events for information dissemination.
Provider level
Stakeholders identified the lack of providers in rural areas,
specifically pediatric providers, as a significant barrier to
HPV vaccine acceptance. Provider shortages in rural areas
were described as resulting in fewer opportunities to interact
with parents and adolescents about the HPV vaccine.
The lack of a medical home for many rural adolescents was
discussed as a challenge to HPV vaccine uptake. Stakeholders
observed that children generally see health care providers less
frequently as they age. Adolescents may see a provider for sick
visits or sports physicals, but many adolescents do not have
regular well visits where the HPV vaccine might be discussed.
When adolescents see providers less frequently, parents may
not have the opportunity to develop a trusting relationship
with providers, and this can impede effective communication
about HPV vaccination. Infrequent use of health care among
adolescents is even more challenging when a series of vaccine
doses require multiple visits, as is the case with the HPV
vaccine.
Stakeholders in both NC and SC also suggested that rural
providers perceive and/or have actual challenges in obtaining,
storing, and getting reimbursement for HPV vaccines. The
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Table 1. Challenges to HPV vaccination in rural areas.
Individual
Level

Provider
Level

Systems
Level

Domain
Vaccine Beliefs/
Misinformation

Quotes
With HPV . . . from the very beginning when it was rolled out you know, there was miscommunication about it and parents
misheard and [thought] it’s all about sex . . . It was like, if we could just rewind time and start with the cancer prevention
message, it would be so different here.
Obviously in the South, where . . . we’re still not allowed to talk about sex in school except under the auspices of
marriage . . . I think we have kind of outdated laws related to how we educate students about sex education and health
education in general . . . especially in more conservative communities.
Sometimes [parents] come in and say ‘I’ve heard this [HPV vaccine] kills people. I had a friend whose child died’, and it’s
really hard to respond to that cause I’m like, ‘I need to see that exact case, but I can tell you that if that were real, if they
felt, people investigating . . . that [it] was due to the HPV vaccine, it would not be on the market’. . . . but it’s hard to
convince people of that.
It’s social media . . . It’s fear. . . . They may feel very educated but it’s like a lot of times there’s a lot of misinformation in what
they’ve heard. They misperceive the risks you know . . . I think that they really . . . want to be holistic. You know, they
want to do the best thing for their child.
. . . there isn’t a huge percentage of [people who choose vaccine] exemptions, but they’re loud and they’re challenging to
deal with because they’re very opinionated, they’re very vocal and often very unfriendly and of course you know, as
a nurse, you don’t want to be confrontational.
Valuation of preventive health They’re not necessarily . . . valuing or understanding the value of primary care and the value of having a medical home.
care
[It’s] the lack of understanding of the importance of healthcare, the lack of understanding of the importance of education.
The parent didn’t get a lot of education, [they don’t] see the value in it for their kids . . . and you know, they certainly
won’t understand a lot about the value of vaccination.
Shortage of providers
I’ve worked with . . . STATE PUBLIC HEALTH AGENCY and they have rural pilot sites that have just not even been able to get
their projects off the ground due to just, lack of resources, not having the correct qualified providers.
It’s still an access issue that I think that we are seeing being a problem, people not getting the vaccines that they need cause
if they can’t get into a VFC provider and they can’t get into the [STATE PUBLIC HEALTH AGENCY], if they’re too young to
go to a pharmacist, then where are they gonna go and get the vaccine from?
While there’s VFC providers there, you have to hope that those VFC providers have the ability to take on new patients.
So, if a clinic does not have an RN, so the RN has to give the injection, if you are an [medical assistant] working under, you
cannot do that. It has to be. So, a lot of our small practices only have medical assistants, so it’s the doctor that has to
give the injection which is another workflow.
Lack of Medical Home
They don’t get primary care and then I think so when they, it’s rare that they get primary care, if they do, they’re going to
a clinic for a sick visit. They’re not going to a medical home, they’re not necessarily [. . .] kind of valuing or understanding
the value of primary care and the value of having a medical home.
...they may not come in for well child checks. It’s not a priority for parents at that point. They’re not thinking, my kid needs
a physical when they’re eleven, twelve. They’re pretty much done with that at a you know, young age after they go to
kindergarten, they may not even get-well child checks when they’re in elementary school.
...but it is hard to get parents, as children age up, to take those to the provider, just a regular provider you know, for things
when they’re not, like they’re not sick or don’t have an immediate you know, reason to go see and so you’re fighting that
battle
Lack of Strong Provider
Some of the providers, especially family practice, maybe are not as up-to-date on the reasons for the vaccine, the
Recommendation
availability of the vaccine, the recommendations for the vaccine, how to present the vaccine and the importance of the
vaccine. And so, I think sometimes . . . there are not strong recommendations made to that population.
I’ve heard a lot of these concerns, having staff . . . that’s comfortable, working with the vaccine schedule and promoting the
vaccines . . . confidently [and] . . . not understanding what the arguments are and really not pushing back [against
parent concerns/misinformation].
A doctor comes in the room with the parent and says ‘Look, you need to have Tdap today. That’s recommended for school,
you need [it] . . . It’s also required that you get meningococcal and then there’s another one, it’s called HPV . . . and as
soon as you say, . . . ‘sex’, you know, the parent says, ‘Well my kid’s not having sex. My kid’s eleven years old . . . and you
know, they don’t need that right now. They can get that later’. . . . and then later comes and then they become an
adolescent and then when do you come back in?
Participation in VFC program As far as rural [barriers, there’s] access to care, insurance, people knowing that those vaccines are gonna be covered, the
physicians, the providers storing . . . the vaccines and afford[ing] them, and I feel like okay, my entire life savings [are]
locked up in this refrigerator and I can’t afford a generator.
I think that there’s definitely some [provider] pushback. The first thing we always hear about is, ‘We can’t do [the VFC
program] because we can’t afford a $5,000 pharmaceutical refrigerator. I’m a small rural practice you know. We barely
make enough money as it is’. So, that’s one common misconception that we have to then educate them on to say, it
doesn’t have to be a pharmaceutical refrigerator.
Some people see [the state vaccine registry system] as, ‘Oh, it’s Big Brother checking us out’, and really that isn’t what we
use it for. We don’t have the policing ability to just sit there and say . . . Dr. So and So’s office is out [of vaccines] again . . .
Reimbursement
Thinking about the payment . . . I think that’s another complexity within the schools. Each kid can have a different health
insurance plan and you know, who’s gonna fund that [school-based vaccinations] for sustainability?
Broadband Connectivity
[Providers] can have spotty Wi-Fi. Obviously, they’re gonna have some internet connection. They don’t even have to have
Wi-Fi really, but they just have to have the ability to upload [vaccine data] to the cloud, so that way [vaccinations] can
be monitored by them and [the state public health agency] can also monitor it.
For many of our rural families, transportation, communication, you know even if they had a connection to a primary
practice you know, the parent may not get a robocall because they may not have access to a cell phone or a cell phone
that doesn’t have minutes for the whole month. Bandwidth is a big issue in this state.
Recommended vs. required
Well, I think number one is, it’s not required, it’s a recommended vaccine.
If you have a choice of three vaccines, Tdap, meningococcal, HPV and the doctor says well in order to go to middle school, this
child needs Tdap, meningococcal, but we recommend HPV, the parent may say, ‘Just give the two that they haveto have’.
HPV, meningococcal are not required [in South Carolina], and so . . . people get exactly what they need to get into the
school and then they’re good.
Several years ago, we went to the [state public health agency] and presented the recommendations to make all ACIP
vaccines required . . . for adolescents. . . . HPV was discussed and it was decided [not to do this] at the time . . . , that
based on what they felt like would be a lot of pushback from the public, from the parents.
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Table 2. Opportunities to improve HPV vaccination rates in rural areas.
Opportunity
Individual Multimodal messaging to address
misinformation and lack of
information

Quotes
Accurate information versus false information on social media—that’s a big one. I would think posters, brochures,
any type of handout that students could take or parents could have access to, like in the health department or at
local health fairs.
It would be great to figure out how [HPV vaccine] information can be disseminated to the parents in rural areas . . .
cause if the school’s not pushing it or . . . educating about it, where are [parents] getting their messaging? . . . They
may not be seeing billboards or on Twitter or anything like that.
There’s gonna have to be really strong education about . . . cancer prevention versus STD prevention, and . . . strong
infrastructure that supports whoever is implementing that within the schools who can know how to respond to
the [parent] pushback and misinformation.

Provider
Level

Training
School based programs

Systems
Level

Collaboration with schools and other
community organizations

Schools are a trusted kind of voice in the community. So, if the school is talking about it and we get the providers
talking about it, I think that would help, a lot. And you know . . . a lot of times the school is the main resource for
kids.
Making sure that the staff inside the office are saying the same message too, because if the doctor is telling you
something and the nurse says something [else], and then at checkout you have the front desk clerk saying, ‘Oh,
you don’t really need the HPV [vaccine]’, then . . . what’s the message now to the parent?
If those school nurses are health department employed, then yes, they do give vaccines and they’re doing that under
the umbrella of the health department. School nurses that are employed by the school district itself only provide
a supportive role in that. In other words, they might do the communication, they might get the consent forms,
they might help to run the venue . . . but they won’t be administering the vaccines because they are not protected
under that umbrella.
School nurses, in general, are really onboard. They definitely understand and are promoters . . . of vaccines.
I’d start with the superintendent and the local health director you know, . . . . So, if there was a presence like that,
whoever would be in charge of that to engage them, then they say, hey, go ahead you know, there’s a tapping of
the form that I don’t know, to give that opportunity to be a part of that conversation.
In those counties specifically, COUNTIES, they’ve got some really good leadership through their school health services
leaders, people that have been there a long, people that have been there a long time, it would be worth talking to.
The school health nurses in particular.
The people that need to be promoting it in those communities need to be part of those communities. I mean cause
for me to go in and you know, a black church and say hey, you know we really should be doing this, it’s not gonna
go over as well I think as somebody that’s, my child had this, and I think it’s really important cause my mother
died of cervical cancer.

Expanded school-based vaccination
services

I do think having a faith-based champion would be really helpful cause I think that is a potential barrier, not just in
rural areas, but potentially more.
We have started reviewing student’s immunization records annually, instead of just once while they’re in middle
school and we actually send out permission forms because we require written consent from the parents for the
student to have a vaccine in the school-based health centers and we are available and have a trained RN who
does immunizations to answer any questions and provide accurate information to the parent or guardian.

Vaccines for Children (VFC) program is a federally funded
program that provides vaccines at no cost to children and
adolescents who might not otherwise be vaccinated because of
inability to pay.22 Several stakeholders in South Carolina
reported that providers perceived the “red tape” related to
VFC program participation VFC as a significant barrier.
Specifically, vaccine ordering, storage requirements, and
monitoring were seen as burdensome. In addition, lack of
consistent high-speed internet required for reporting to the
state registry may pose a barrier to VFC program participa
tion among rural providers.
Stakeholders reported that lack of strong provider recom
mendation as a significant challenge to HPV vaccination.
Provider and staff training were considered essential to ensure
that all providers are conveying consistent, accurate messages
regarding HPV vaccination. Stakeholders in both NC and SC
recommended additional training for providers and staff in
medical offices so that parents hear a unified message regarding
the importance of HPV vaccination. Stakeholders noted that
providers needed assistance in presenting strong and consis
tent information on the need for HPV vaccination and the
importance of vaccinating during early adolescence. Assisting

HPV providers in ‘pushing back’ against false vaccination
beliefs was also identified as a need, and stakeholders strongly
endorsed a continued focus on ‘HPV vaccination as cancer
prevention’ messaging.

Systems level
Stakeholders highlighted one key systems level barrier: lack of
state-level mandates for the HPV vaccine for school enroll
ment. The HPV vaccine is currently recommended for adoles
cents but is not required in either NC or SC for enrollment in
public schools. Most stakeholders identified this as an impor
tant contributor to low vaccine coverage. Stakeholders indi
cated that, for parents, the fact that HPV vaccination is not
required for school entry may be interpreted to mean that it is
not a priority. One stakeholder suggested that when many
things are required in a visit, parents may opt to forgo the
“recommended but not required” vaccines to speed the visit
and/or reduce the number of shots their child has to receive at
one visit. Stakeholders also reported that the lack of a school
mandate for HPV vaccination causes some providers to pre
sent the HPV vaccine as “optional” or “an add-on” to core
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services, which, in turn, may foster false beliefs among parents
that the HPV vaccine is not as critical for children as the
required vaccines.
To increase HPV vaccination rates, stakeholders suggested
that state and local organizations could build on successful
programs such as existing statewide teen pregnancy prevention
programs. In addition, stakeholders noted that current efforts
to improve rural primary care (i.e., a statewide pilot program in
NC) to make it more welcoming to adolescents could be
expanded to include adolescent vaccination. Capitalizing on
ongoing programs and initiatives targeting health and wellness
in adolescents were noted to be prime opportunities to increase
HPV vaccine coverage.
A number of stakeholders recommended collaborating with
local leaders in rural areas to develop and implement HPV
vaccine education programs for adolescents and parents at the
local level. While statewide efforts can help improve vaccine
coverage, local area initiatives and collaboration with local key
opinion leaders were deemed essential to increase HPV vacci
nation rates in rural areas. Examples of key opinion leaders
include the health department, school administrators, or those
involved in school health programs at the county level. For
example, a number of school systems in NC and SC have
established strong relationships with the local public health
departments. These collaborations have supported initiatives
such as having county health department nurses come into the
school and provide required vaccines. Stakeholders noted that
this strategy was needed because school nurses employed by
local public school systems are typically not able to provide
vaccinations. Combining onsite vaccination and vaccine edu
cation in school settings has the potential to address both local
norms and misinformation around vaccination and accessrelated challenges that rural families experience.
Several stakeholders discussed the process of school nurses
reviewing vaccination records at the beginning of the school year
to identify students who are not up-to-date on public schoolmandated vaccines such as Tdap (in both NC and SC) and
MenACWY (in NC only). School nurses also take this opportu
nity to remind parents to get recommended vaccines for their
adolescents, including HPV and influenza. This process occurs
yearly and offers an ongoing opportunity to provide information
to parents about recommended vaccinations and to provide
families with resources to address logistical challenges to vacci
nations. Stakeholders remarked on the importance of school
nurses providing strong recommendations for HPV—especially
in rural communities with shortages of pediatric providers.

Discussion
The results from this study of key stakeholder perspectives in
NC and SC offer insights into challenges and opportunities to
increase HPV vaccination in rural communities. Stakeholders
noted challenges to HPV vaccination specific to rural commu
nities such as the shortage of providers and limited broadband
connectivity. The stakeholders also identified challenges that
were nonspecific to rural areas, such as vaccine misinformation
and concerns about HPV vaccine safety. Some of these chal
lenges, especially vaccine misinformation and vaccine hesi
tancy, have intensified during the COVID-19 pandemic.23 In

the early days of the pandemic, fewer adolescents received
vaccines, leading to a drop in adolescent vaccination
coverage.24 Further research is warranted to understand the
full impact of the COVID-19 pandemic on adolescent vaccina
tion coverage and challenges to vaccination.
Stakeholders brought up several systems-level challenges
not previously discussed in detail in the literature.
Participants identified limited access to high-speed internet
as a barrier that may create challenges for rural providers
in terms of ordering vaccines and exchanging vaccine data
efficiently with state registries. Evidence suggests that low
resource practices such as those in rural areas may not have
the technological expertise or infrastructure to engage with
health information technology.25 Further, limited internet
connectivity can pose barriers to information dissemination
to parents via social media or other web-based modalities.
Recent efforts to increase broadband access in rural areas
have included investing in infrastructure and providing
resources to local and state governments to increase inter
net connectivity.26 Stakeholders in both NC and SC also
identified the lack of statewide mandates on HPV vaccina
tion for public school enrollment as a significant barrier—
though this barrier would apply to both rural and urban
adolescents enrolled in public schools. Evidence from
Rhode Island suggests that requiring HPV vaccination for
school entry can boost coverage rates for the vaccine.27,28
While most stakeholders suggested that the lack of HPV
vaccine requirement was a significant barrier to uptake,
most also acknowledged that inadequate political support
to enact such policies in NC and SC.
Stakeholders identified a number of opportunities to
increase HPV vaccine coverage through school-based strate
gies and interventions in rural NC and SC. Collaboration with
schools was cited as an optimal way to reach rural parents and
adolescents to increase HPV vaccine initiation and completion
as schools were noted to play a central, and often unifying, role
in small rural communities. For example, NC has a network of
school-based health centers, with many serving families in
rural areas who otherwise would have difficulty accessing pri
mary care services. Previous research supports HPV vaccina
tion programs in school-based health centers and identifies the
need to improve systems to coordinate across health and
school systems.29 In addition, collaborating with school nurses
was identified as a promising strategy for reaching adolescents
and parents. A recent study from SC found that most school
nurses in leadership roles believed the HPV vaccine should be
given to male and female preteens and that the HPV vaccine
was safe, nontoxic, and prevents HPV cancer.30 However,
challenges that may limit the ability of school nurses to engage
in HPV vaccine promotion may include lack of time, compet
ing responsibilities, and lack of knowledge (e.g. how to work
with vaccine hesitant parents). As school nurses can play an
integral role in facilitating adolescent vaccinations, further
research is needed to address challenges and to support school
nurses in delivery of HPV vaccine information programs.
There are several limitations to this study. First, there
may be limited generalizability as this study focused on
a small sample of key stakeholders in NC and SC. Second,
because stakeholders knew this study was being conducted
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as part of a broader initiative to develop a school-based
HPV vaccination promotion intervention, social desirability
bias may have influenced them to speak more positively
about the role that schools and school nurses can play in
increasing rural HPV vaccination. Extending this work
through the collection of quantitative survey data with
a large and diverse sample of school stakeholders (e.g.,
school nurses, administrators) would be useful.

Conclusion
Many persistent individual, provider and system level challenges
to HPV vaccination in rural areas were identified (e.g., lack of
access, missed opportunities during provider-patient encounters,
competing priorities for rural families), suggesting the need to
accelerate efforts to address rural vaccination challenges.
Stakeholders highlighted the central role that schools play in
many rural communities—including serving as key avenues for
providing resources, education, and even healthcare to children
and their families. Individuals strongly supported school-based
programs and approaches to strengthen confidence and demand
in HPV vaccination and to help address persistent social determi
nants of health (e.g., poverty, transportation challenges, and health
care disparities) that continue to persist in many rural areas.
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